Anticoagulation in COVID-19: effect of enoxaparin, heparin, and apixaban on mortality
HH Billett, M Reyes-Gil, J Szymanski… - Thrombosis and …, 2020 - thieme-connect.com
Background Mortality in coronavirus disease of 2019 (COVID-19) is associated with
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has
been proposed as therapy to decrease mortality, often adjusted for illness severity. Objective
We wanted to investigate whether anticoagulation improves survival in COVID-19 and if this
improvement in survival is associated with disease severity. Methods This is a cohort study
simulating an intention-to-treat clinical trial, by analyzing the effect on mortality of …
increases in prothrombotic parameters, particularly D-dimer levels. Anticoagulation has
been proposed as therapy to decrease mortality, often adjusted for illness severity. Objective
We wanted to investigate whether anticoagulation improves survival in COVID-19 and if this
improvement in survival is associated with disease severity. Methods This is a cohort study
simulating an intention-to-treat clinical trial, by analyzing the effect on mortality of …
[引用][C] Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin and Apixaban on Mortality (preprint)
以上显示的是最相近的搜索结果。 查看全部搜索结果